Bioactivity:

VPC-13163 has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line. It also inhibits Prostate Specific Antigen (PSA) in both LNC

CAS nr:

6637/10/1

Purity:

98%

Molecular Weight:

234,3

SMILES:

C1(C2=CNC3=C2C=CC=C3)NC4=C(C=CC=C4)C1

Formula:

C16H14N2

Pathway:

Others

Target:

Others